DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Tanomastat
Tanomastat
Nitrate Prodrugs Able to Release Nitric Oxide in a Controlled and Selective
Tanibirumab (CUI C3490677) Add to Cart
Modifications to the Harmonized Tariff Schedule of the United States To
I Regulations
Advice Concerning the Addition of Certain Pharmaceutical Products
The Pharmacological TAILS of Matrix Metalloproteinases and Their Inhibitors
(12) United States Patent (10) Patent No.: US 8,158,152 B2 Palepu (45) Date of Patent: Apr
Stembook 2018.Pdf
(12) Patent Application Publication (10) Pub. No.: US 2008/0207605 A1 Spada (43) Pub
Reference: WLI/100 31 January 2008
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
Pharmaabkommen A1 E
Customs Tariff - Schedule Xxi - 1
(12) Patent Application Publication (10) Pub. No.: US 2016/0082123 A1 RAU Et Al
(12) Patent Application Publication (10) Pub. No.: US 2010/0226943 A1 Brennan Et Al
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances 2009
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Top View
WO 2012/170676 Al 13 December 2012 (13.12.2012) P O P C T
INN-Nimet 1 20.8.2019 a Abacavir Abacavirum Abakaviiri
Recent Advances in MMP Inhibitor Design